U.S., Aug. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07099976) titled 'PromotIng Optimal Treatment for Community-acquired PNeumonia in EmErgency Rooms' on April 28.

Brief Summary: In North America, up to 5% of preschoolers develop community-acquired pneumonia (CAP) every year. Pneumonia is the second-leading reason for paediatric hospitalization in both Canada and the US; approximately 20% of children hospitalized with CAP may need intensive care, which can result in significant morbidity. Given this burden of disease, it is critical that CAP is managed appropriately. Specific therapy for CAP is dependent on microbiologic aetiology, as bacterial disease will improve with antibiotic treatment.

Study Sta...